Zusammenfassung
Hintergrund
Die Arteriitis temporalis (AT) zeigt als systemische Vaskulitis sehr variable klinische Krankheitsverläufe, bei der vorübergehende oder permanente Sehstörungen auftreten können.
Patienten und Methode
Es handelt sich um eine retrospektive konsekutive Fallserie von 66 Patienten mit Verdacht auf AT, von denen 65 einer Biopsie der A. temporalis unterzogen wurden. Die Beschwerdesymptomatik, Therapie sowie Komplikationen während des Krankheitsverlaufs wurden verfolgt.
Ergebnisse
Bei 32 (49,2%) von 66 Patienten konnte bei ein- (55,4%) oder beidseitiger (44,6%) Biopsie histopathologisch eine Riesenzellarteriitis nachgewiesen werden. Davon zeigten 3 Patienten (9,4%) schwerwiegende bis letale Folgen: ausgeprägte Ischämien des vertebrobasilären Systems mit konsekutiver Schwerstbehinderung bzw. Exitus bei je 1 Patienten sowie 1 letale Komplikation einer akuten Pankreatitis als Nebenwirkung der systemischen Steroidtherapie.
Schlussfolgerung
Die AT als potenziell lebensbedrohliche Systemerkrankung erfordert eine umsichtige und unverzügliche interdisziplinäre Diagnostik und Behandlung. Bei systemischer Manifestation führt sie zu einer deutlichen Minderung des Allgemeinzustandes, in deren Folge häufig zerebrale ischämische Ereignisse oder Organinfarzierungen auftreten können.
Abstract
Background
Arteritis temporalis (AT) shows a variable course of the disease and may lead to transient or permanent visual loss.
Patients and methods
In a retrospective consecutive case series 66 patients with suspected AT were followed up of which 65 underwent arterial biopsy. Symptoms, therapy and complications were followed up.
Results
Of the patients 32 (49.2%) revealed a positive histological finding in unilateral (55.4%) or bilateral (44.6%) biopsy. Of these 3 (9.4%) suffered a severe or fatal outcome: two with extensive ischemia of the vertebrobasilar system (one fatal) and one patient died due to acute pancreatitis, a rare side effect of systemic steroid therapy.
Conclusion
When systemically apparent, arteritis temporalis can progress to reduction of general health, cerebral ischemia and organ infarction. Therefore, AT is a serious disease requiring interdisciplinary, immediate diagnostics and prompt therapy.
Literatur
Brack A, Martinez-Taboada V, Stanson A et al (1999) Disease pattern in cranial and large vessel giant cell arteritis. Arthritis Rheum 42(2):311–317
Carroll SC, Gaskin BJ, Danesh-Meyer HV (2006) Giant cell arteritis. Clin Experiment Ophthalmol 34(2):159–173
Caselli RJ, Hunder GG, Whisnant JP (1999) Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 38(3):352–359
Chrousos GA, Kattah JC, Beck RW, Cleary PA (1993) Side effects of glucocorticoid treatment. Experience of the optic neuritis treatment trial. JAMA 269(16):2110–2112
Danesh-Meyer HV, Savino PJ (2007) Giant cell arteritis. Curr Opin Ophthalmol 18(6):443–449
Danesh-Meyer HV, Savino PJ, Eagle RC Jr et al (2000) Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol 20(3):213–215
Hayreh SS, Podhajsky PA, Raman R, Zimmerman B (1997) Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 123(3):285–296
Hayreh SS, Podhajsky PA, Zimmerman B (1998) Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 125(4):521–526
Herlyn K, Hellmich B, Gross WL, Reinhold-Keller E (2008) Stable incidence of systemic vasculitides in Schleswig-Holstein, Germany. Dtsch Arztebl Int 105(19):355–361
Horton BT, Magath TB, Brown GE (1932) An undescribed form of arteritis of the temporal vessels. Proc Mayo Clin 7:700–701
Hutchinson J (1890) Diseases of the arteries. On a peculiar form of thrombotic arteritis of the aged which is sometimes productive of gangrene. Arch Surg 1:323–329
Julve Pardo R, Garcia-Escrig M, Catala Barcelo J et al (1998) Acute pancreatitis as an effect of IV methylprednisolone in the treatment of optical neuritis. Neurologia 13(7):372–373
Karahaliou M, Vaiopoulos G, Papaspyrou S et al (2006) Colour duplex sonography of temporal arteries before decision for biopsy: a prospect study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 8(4):R116
Kawasaki A, Purvin V (2009) Giant cell arteritis: an updated review. Acta Ophthalmol 87:13–32
Lie JT (1978) Disseminated visceral giant cell arteritis: histopathologic description and differentiation from other granulomatous vasculitides. Am J Clin Pathol 69:299–305
Miller NR (2001) Visual manifestation of temporal arteritis. Rheum Dis Clin North Am 27(4):781–797
Ness T, Auw-Hädrich C, Schmidt D (2006) Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment. Ophthalmologe 103(4):296–301
Parikh M, Miller NR, Lee AG et al (2006) Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 113(10):1842–1845
Pfadenhauer K, Weber H (2006) Ultrasonography of the temporal, periorbital and carotid arteries in the diagnosis of giant cell arteritis and its neuroophthalmological complications. Ultraschall Med 27(4):329–335
Rüegg S, Engelter S, Jeanneret C et al (2003) Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine (Baltimore) 82(1):1–12
Salvarani C, Crowson CS, O’Fallon WM et al (2004) Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 51(2):264–268
Salvarani C, Giannini C, Miller DV, Hunder G (2006) Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum 55(6):985–989
Schmidt D, Hetzel A, Reinhard M, Auw-Haedrich C (2003) Comparison between color duplex ultrasonography and histology of the temporal artery in cranial arteritis (giant cell arteritis). Eur J Med Res 8(1):1–7
Schmidt D, Vaith P, Hetzel A (2001) Prevention of serious ophthalmic and cerebral complications in temporal arteritis? Clin Exp Rheumatol 18 (Suppl 20):61–63
Seneviratne DR, Mollan SP, Elsherbiny S, Worstmann T (2008) Giant cell arteritis complicated by acute pancreatitis: a case report. J Med Case Rep 2:346
Sheehan MM, Keohane C, Twomey C (1993) Fatal vertebral giant cell arteritis. J Clin Pathol 46(12):1129–1131
Spiera RF, Kupfersmith M, Paget S, Spiera H (2003) Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al. Arthritis Rheum 48(4):1159–1160; author reply 1160–1161
Weyand CM, Goronzy JJ (2003) Giant cell arteritis and polymyalgia rheumatica. Ann Intern Med 139(6):505–515
Weyand CM, Ma-Krupa W, Goronzy JJ (2004) Immunopathways in giant cell arteritis and polymyalgia theumatica. Autoimmun Rev 3(1):46–53
Wiszniewska M, Devuyst G, Bogousslavsky J (2007) Giant cell arteritis as a cause of first-ever stroke. Cerebrovasc Dis 24(2–3):226–230
Zhou L, Luneau K, Weyand CM et al (2009) Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases. Ophthalmology 116(8):1574–1580
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brüggemann, A., Holl-Ulrich, K. & Müller, M. Klinische Aspekte der Arteriitis temporalis. Ophthalmologe 107, 930–936 (2010). https://doi.org/10.1007/s00347-010-2164-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-010-2164-1
Schlüsselworter
- Arteriitis temporalis
- Riesenzellarteriitis
- A.-temporalis-Biopsie
- Systemische Vaskulitis
- Letale Komplikationen